COSCIENS Biopharma Inc T.CSCI

Alternate Symbol(s): CSCI

Healthcare Biotechnology

COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.

TSX:CSCI - Post by User

COSCIENS Biopharma Inc > Adult trial failed to meet primary endpoint but was approved

<< Previous

Bullboard Posts

Next >>

Post by fossi_2002on Aug 27, 2024 11:50am

116 Views

Post# 36197783

Adult trial failed to meet primary endpoint but was approved

Proph... is grasping at the last straw. Everything is useless. Further losses loom and the listing on the NASDAQ is a distant prospect. In order for Gilles to achieve his goal, he will consider another share consolidation.
We - Oats and Ciao and all other shareholders - should all pull together to ensure that the Gilles era ends as soon as possible.

<< Previous

Bullboard Posts

Next >>

The top 5 mining dividend stocks in Canada